Stage IV Vulvar Cancer AJCC v8

7 clinical trials · Condition

Record	Firm	Date
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer (NCT07741968)	City of Hope Medical Center	2027-02-22
Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer (NCT07226102)	City of Hope Medical Center	2026-07-16
e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study (NCT05786456)	City of Hope Medical Center	2024-07-19
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients (NCT03987555)	Wake Forest University Health Sciences	2019-11-11
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers (NCT03439085)	M.D. Anderson Cancer Center	2018-11-14
Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers (NCT03452332)	M.D. Anderson Cancer Center	2018-07-18
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer (NCT02140021)	M.D. Anderson Cancer Center	2014-10-27

Every clearance here is in the API, with alerts when new ones post.